tirzepatide 1 month before and after I was nervous to start, but in -16.1 lbs later, I’m so glad I took the leap. Compound has been the tool I needed to finally make my healthy habits stick. It’s not a “magic 6 months. One powerful transformation.

Most payers require documented obesity diagnosis, BMI criteria, and evidence that behavioral interventions were attempted before approving Zepbound, making first-pass complete documentation especially important for this drug class

Manufacturer assistance programs and patient advocacy organizations offer copay reduction resources, but eligibility requires navigating separate application processes outside insurance structures

3 Mohn, E.S., Kern, H.J., Saltzman, E., Mitmesser, S.H., McKay, D.L

GLP-1 receptor agonists and dual GIP/GLP-1 agonists like tirzepatide have specific warnings regarding potential interactions with oral contraceptives due to their effects on gastric motility

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Skipping COA verification